Somatic alpha-synuclein mutations in Parkinson's disease: hypothesis and preliminary data

Area of Science:

• Neuroscience
• Genetics
• Pathology

Background:

• Alpha-synuclein (SNCA) is central to Parkinson's disease (PD) pathogenesis, but SNCA gene mutations are infrequent.
• Somatic genetic variations, including in the brain, are increasingly recognized, yet their role in disease remains unclear.
• Somatic SNCA mutations arising during development could cause PD mosaicism, undetectable in peripheral DNA.

Purpose of the Study:

• To investigate the hypothesis that somatic SNCA mutations contribute to PD pathogenesis.
• To determine if a novel SNCA mutation (p.H50Q) exhibited mosaicism in PD brain-derived DNA.
• To screen PD brain DNA for additional SNCA mutations using sensitive methods.

Main Methods:

• PCR and cloning strategy utilizing an intronic polymorphism to detect mosaicism for the p.H50Q SNCA mutation.
• High-resolution melting curve analysis of SNCA coding exons in 28 PD brain-derived DNA samples.
• Review of existing genetic, embryological, and pathological data supporting the somatic SNCA mutation hypothesis.

Main Results:

• No evidence of mosaicism was found for the p.H50Q SNCA mutation in the analyzed PD brain DNA.
• High-resolution melting curve analysis did not reveal any further SNCA mutations in the 28 PD brain samples.
• The somatic SNCA mutation hypothesis is presented as consistent with current data.

Conclusions:

• The study did not find evidence supporting mosaicism for the specific novel SNCA mutation investigated.
• Further research on brain-derived DNA, using diverse regions and methods for genomic variation detection, is warranted.
• The role of somatic SNCA mutations in Parkinson's disease requires continued investigation.